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Abstract
The neural cell adhesion molecule L1 is critical for brain development and plays a role in learning and memory in the adult.
Ethanol inhibits L1-mediated cell adhesion and neurite outgrowth in cerebellar granule neurons (CGNs), and these actions
might underlie the cerebellar dysmorphology of fetal alcohol spectrum disorders. The peptide NAP potently blocks ethanol
inhibition of L1 adhesion and prevents ethanol teratogenesis. We used quantitative RT-PCR and Western blotting of extracts
of cerebellar slices, CGNs, and astrocytes from postnatal day 7 (PD7) rats to investigate whether ethanol and NAP act in part
by regulating the expression of L1. Treatment of cerebellar slices with 20 mM ethanol, 10
212 M NAP, or both for 4 hours,
24 hours, and 10 days did not significantly affect L1 mRNA and protein levels. Similar treatment for 4 or 24 hours did not
regulate L1 expression in primary cultures of CGNs and astrocytes, the predominant cerebellar cell types. Because ethanol
also damages the adult cerebellum, we studied the effects of chronic ethanol exposure in adult rats. One year of binge
drinking did not alter L1 gene and protein expression in extracts from whole cerebellum. Thus, ethanol does not alter L1
expression in the developing or adult cerebellum; more likely, ethanol disrupts L1 function by modifying its conformation
and signaling. Likewise, NAP antagonizes the actions of ethanol without altering L1 expression.
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Introduction
The L1 neural cell adhesion molecule is critical for brain
development. L1 mediates cell-cell interactions, neuronal migra-
tion, neurite outgrowth, axon guidance and fasciculation, and
neuronal survival in the developing nervous system [1]. L1
expression persists in the adult nervous system, where it is believed
to play a role in learning, memory, and regeneration after injury
[2–5]. L1 gene mutations cause a spectrum of dysmorphic lesions,
including hydrocephalus, agenesis or hypoplasia of the corpus
callosum, and cerebellar dysplasia, referred to as CRASH or L1
syndrome [6,7]. The similarity of the lesions of L1 syndrome to
those of fetal alcohol spectrum disorders (FASD) led to the
hypothesis that ethanol causes FASD in part by disrupting L1-
mediated processes [8,9]. In support of this hypothesis, concen-
trations of ethanol attained after one drink inhibit L1-mediated
cell-cell adhesion (L1 adhesion) in transfected fibroblasts, neural
cell lines, and cerebellar granule neurons (CGNs) [8–10].
Furthermore, ethanol inhibits L1-mediated neurite outgrowth in
CGNs at similarly low concentrations [11]. Finally, drugs that
block ethanol inhibition of L1 adhesion also prevent ethanol
teratogenesis in mouse embryos [12–15]. One such ethanol
antagonist, the peptide NAPVSIPQ (NAP), blocks ethanol
inhibition of L1 adhesion at femtomolar concentrations [16].
Several mechanisms might account for how ethanol disrupts L1
function. Recent data suggest that ethanol alters extracellular
domain interactions that are critical for L1 homophilic binding
[17,18]. Ethanol also disrupts L1 activation of intracellular
signaling events [19,20]. It is unknown whether regulation of L1
expression also contributes to ethanol neurotoxicity. Reductions in
L1 expression could not occur rapidly enough to account for acute
ethanol inhibition of L1 adhesion; however, changes in L1
expression after longer periods of ethanol exposure would disrupt
both L1 adhesion and L1-mediated neurite outgrowth. Further-
more, NAP-induced up-regulation of L1 expression could partly
compensate for ethanol inhibition of L1 adhesion.
Ethanol damages the developing and adult cerebellum [21–23].
Because L1 is critical for cerebellar development and survival of
cerebellar neurons [1,24], ethanol could damage the cerebellum by
altering the expression of L1. Indeed, another teratogen, poly-
chlorinated biphenyls (PCBs), significantly reduced L1 expression in
wholecerebellum [25].Theeffectsofethanol onL1expression have
not been well studied. Chronic ethanol treatment did not reduce L1
protein expression in the NG108-15 neural cell line [9] and
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vtransiently increased L1 gene expression in B104 neuroblastoma
cells [26]. However, it is unknown whether ethanol modulates the
expression of L1 in cerebellum, nor whether NAP antagonizes
ethanol inhibition of L1 function by increasing L1 expression.
We systematically investigated the effects of ethanol and NAP
exposure on L1 mRNA and protein expression in cerebellar slices,
CGNs, and astrocytes of postnatal day 7 (PD7) rats. Vulnerability
to binge alcohol-induced cerebellum damage is greatest during
PD4-PD9 in rats, the period that corresponds to gestational weeks
24–32 in humans [27,28]. At this developmental stage, cerebellar
neurons undergo neuritogenesis and express high levels of L1
[2,29]. Because alcoholics frequently develop cerebellar degener-
ation [23,30], we also examined the effects of long-term binge
drinking on L1 expression in adult rat cerebellum. Here we
present evidence that ethanol does not regulate L1 expression in
the developing or adult cerebellum. Similarly, NAP or the
combination of ethanol and NAP do not alter L1 mRNA or
protein levels in the developing cerebellum.
Results
Quality control, assay reliability, and validation of
endogenous controls
High-quality RNA preparations are necessary to insure that
measured quantities of gene transcripts are representative of in vivo
expression levels [31]. Therefore, the 28S:18S ribosomal RNA
(rRNA) ratios, RNA integrity numbers (RINs), and yield were
measured for every RNA sample prior to use in quantitative
reverse transcription PCR (qRT-PCR). All samples had an RIN
above 8.5 (data not shown), and treatment with ethanol did not
degrade RNA quality (Fig. 1A). Average quantification cycle
values (Cq) were linear (R
2=0.9995) with log-transformed L1
transcript concentration over at least six log orders (Fig. 1B).
Average quantification cycle (Cq) values from control and ethanol-
treated samples were used to evaluate the stability of potential
endogenous control genes, and 18S rRNA (18S) was found to be
more stable than cyclophilin A (not shown) in all cell and tissue
types (Fig. 1C). Due to its stability with ethanol treatment, 18S was
used to normalize all L1 mRNA expression data. Similarly, we
evaluated the effects of ethanol on levels of expression of candidate
endogenous protein controls, including b-tubulin (Fig. 1D),
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and actin
(not shown). Among these, only b-tubulin protein expression was
unaffected by ethanol treatment in all three culture preparations.
Effects of ethanol and NAP on L1 expression in early
postnatal cerebellum
We first determined relative levels of L1 mRNA in the different
culture preparations. L1 expression was 62.164.2% lower in CGNs
than in slices and 99.960.01% lower in astrocytes than in slices
(n=4; p,0.0001 for each comparison)(Fig. 2A). To determine the
effects of ethanol and NAP on L1 expression, cerebellar slices from
PD7 rats were exposed to 20 mM ethanol, 10
212 M NAP, or both
for 4 hours, 24 hours, or 10 days. Treatment with ethanol or NAP
had no effect on levels of L1 mRNA or protein at any of the time
points (Fig. 2B, Table 1). Treatment with ethanol and NAP for 10
days significantly reduced L1 mRNA, but had no significant effect
on L1 total protein expression (Table 1).
Figure 1. RNA quality, assay reliability, and validation of endogenous controls. Total RNA quality was assessed using an Agilent
Bioanalyzer 2100 and endogenous controls were validated for RT-qPCR and Western blot. A) Generated gel images show representative slice, CGN,
and astrocyte samples with and without 24-hr ethanol treatment. B) A standard curve was performed using a dilution series of purified L1 template.
Increases in template concentration result in decreasing Cq values, as expected for a well-functioning qPCR assay (n=4). C) 18S Cq values are shown
for all tissue/cell types with and without ethanol treatment. D) Representative Western blots for b-tubulin are shown for each sample type with and
without 24-hr ethanol treatment. All bars (C, D) show the mean + SEM of 4 independent experiments.
doi:10.1371/journal.pone.0024364.g001
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experiments on slices might obscure opposite effects on different
cell types. Therefore, we conducted separate experiments on
primary cultures of CGNs and astrocytes, the predominant cell
types of the cerebellum. In CGNs, treatment with ethanol, NAP,
or both for 4 or 24 hours had no significant effect on the
expression of L1 mRNA or protein (Fig. 2C, Table 1). L1
expression was significantly lower in astrocytes compared with
CGNs, as previously described [32], but also showed no significant
changes with ethanol, NAP, or combined treatments (Fig. 2A,D).
Higher concentrations of ethanol (100 mM) likewise had no effect
on L1 expression in cerebellar slices, CGNs, and astrocytes (not
shown).
Effects of ethanol and NAP on L1 expression in adult
cerebellum
We used a chronic binge-drinking rat model [33] to evaluate
the effects of ethanol on L1 expression in adult cerebellum. We
measured L1 mRNA and protein expression in whole
cerebellar homogenates from rats that had self-administered
ethanol for more than 12 months, beginning at approximately
2 months of age. Subjects that self-administered ethanol
attained mean blood ethanol concentrations of 100614 mg/
dl (n=6). Cerebellar L1 mRNA and protein levels did not
differ between ethanol-exposed rats (n=6) and sucrose
controls (n=7)(Fig. 3).
Discussion
The major finding of this work is that ethanol does not regulate
L1 gene or protein expression in the developing or adult
cerebellum. Likewise, the alcohol antagonist NAP, either alone
or in combination with ethanol, does not regulate L1 expression in
three models of the developing cerebellum.
Validity of the experimental results
Accurate gene and protein expression analysis requires rigorous
techniques and the appropriate selection of endogenous reference
genes or proteins for the experimental conditions. We followed all of
the recent recommendations for the reliable measurement of mRNA
by qRT-PCR [34,35]. In particular, we isolated high-quality RNA
with an RIN that was consistently higher than 8.5 - well above the
recommended threshold for qRT-PCR [31,36]. Furthermore, we
fully validated our primer pairs and performed standard curves to
verify PCR efficiency and exclude the presence of PCR inhibitors.
Finally, we also verified that our endogenous reference standards -
18S for RNA and b-tubulin for protein – were not influenced by
ethanol treatment in any of the in vitro model systems.
Ethanol does not affect L1 expression in developing
cerebellum
We studied PD7 rats, because the cerebellum is particularly
vulnerable to ethanol exposure at this developmental time point
Figure 2. L1 expression in cerebellar slices, CGNs, and astrocytes. A) Comparison of L1 transcript levels in different culture preparations.
*p ,0.0001 compared to slices. B–D) Total RNA and cell lysates were collected from slice, CGN, and astrocyte cultures after 24-hr exposure to 20 mM
ethanol, 10
212 M NAP, or the combination of NAP and ethanol. L1 mRNA expression was measured by qRT-PCR and normalized to 18S. L1 protein
levels were measured by Western blot and normalized to b-tubulin (representative images shown above corresponding bars). L1 mRNA and protein
levels are shown in cerebellar slices (B), CGNs (C), and astrocytes (D). Legend in B applies to B–D. All bars represent normalized mean + SEM of 4
independent experiments.
doi:10.1371/journal.pone.0024364.g002
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migration, and survival [2,24,37–40]. L1 regulates CGN migra-
tion and axon outgrowth and is a survival factor for CGNs
[24,38,39]; therefore, ethanol-induced reductions in L1 expression
could disrupt cerebellar development. We used three different
model systems to evaluate the effects of ethanol exposure on L1
expression. Cerebellar slices preserve the integrity of cerebellar
circuitry and neuronal-glial interactions in the developing
cerebellum [41]. Cerebellar granule neurons and astrocytes are
the most abundant neuronal and glial cell types, respectively, in
the developing cerebellum and both show ethanol-induced cell
death [42,43]. Treatment with intoxicating (20 mM) or anesthetic
(100 mM) concentrations of ethanol for 4 hours, 24 hours, or 10
days did not reduce L1 expression in cerebellar slices, CGNs, and
astrocytes, with one exception. After 10 days of ethanol plus NAP
treatment, there was a decrease in L1 mRNA in cerebellar slices,
but this was of dubious functional significance, since there was no
corresponding change in L1 protein expression.
Our failure to observe changes in L1 mRNA is not likely a
consequence of the insensitivity of our assays or the unrespon-
siveness of our culture systems to ethanol. Our qRT-PCR assay
was highly sensitive and linear in detecting differences in L1
transcript levels and allowed us to observe significant differences in
L1 expression among cerebellar slices, CGNs, and astrocytes.
Furthermore, the ethanol dose and duration of treatment in these
experiments are sufficient to modify cerebellar physiology [44,45],
neuronal differentiation [11,46], and gene expression [47–51].
Taken together, our findings suggest that ethanol does not disrupt
cerebellar development by altering L1 expression.
Although previous work in CGNs demonstrated that ethanol
inhibits L1 adhesion within 30 minutes [8] and L1-mediated
neurite outgrowth within 12 hours [11,19], our data indicate that
neither of these effects can be attributed to ethanol-induced
reductions in L1 expression. Indeed, recent studies suggest that
ethanolinhibitsL1adhesionbydisruptingtheinteractionsoftheIg1
and Ig4 extracellular domains [17,18]. Further work is required to
learn whether ethanol modulates L1 expression in other cerebellar
cell types, such as Purkinje cells, Golgi neurons, microglia, and
oligodendrocytes. Likewise, it remains to be determined whether
ethanol modulates the subcellular distribution of L1 in CGNs.
Recent studies indicate that ethanol does not change the polarity of
L1 sorting within dorsal root ganglion cells [19].
NAP does not regulate L1 expression in developing
cerebellum
NAP is neuroprotective against a variety of insults, including fetal
alcohol exposure, although the underlying mechanisms are unclear
Table 1. Summary of ethanol and NAP effects on L1 mRNA
and protein expression in three cerebellar culture systems.
Sample type
L1 mRNA (%
RQ±SEM) n p
L1 protein (%
RQ±SEM) n p
Cerebellar slices
4h r
Control 100613 7 - 100 6 -
EtOH 10269 7 0.92 82616 6 0.30
NAP 9164 4 0.59 121659 6 0.73
NAP+EtOH 11469 4 0.46 88621 6 0.60
24 hr
Control 100664 - 1 0 0 4 -
EtOH 104610 4 0.83 76614 4 0.19
NAP 10167 4 0.91 98626 4 0.94
NAP+EtOH 9964 4 0.85 112633 4 0.75
10 day
Control 100610 4 - 100 3 -
EtOH 10868 4 0.45 87640 3 0.80
NAP 9763 4 0.94 100628 3 0.99
NAP+EtOH 65674 0.03 113642 3 0.78
CGNs
4h r
Control 100612 5 - 100 4 -
EtOH 115613 5 0.39 109619 4 0.66
NAP 11866 5 0.24 92610 4 0.50
NAP+EtOH 13167 5 0.07 99632 4 0.98
24 hr
Control 105664 - 1 0 0 4 -
EtOH 9664 4 0.25 109625 4 0.76
NAP 10364 4 0.77 81610 4 0.16
NAP+EtOH 9867 4 0.48 83611 4 0.22
Astrocytes
4h r
Control 100610 3 -
EtOH 85613 3 0.47
NAP 77611 3 0.20
NAP+EtOH 97615 3 0.90
24 hr
Control 100615 8 - 100 4 -
EtOH 114626 6 0.63 111610 4 0.37
NAP 84620 5 0.52 132626 4 0.31
NAP+EtOH 150657 3 0.23 109622 4 0.72
doi:10.1371/journal.pone.0024364.t001
Figure 3. L1 expression in adult cerebellum after chronic binge
drinking. Total RNA and tissue lysates were collected from cerebella of
adult rats following one year of self-administration of ethanol (2%
sucrose/10% ethanol) or sucrose (2% sucrose). L1 mRNA expression was
measured by qRT-PCR and normalized to 18S. L1 protein levels were
measured by Western blot and normalized to b-tubulin. The inset
shows representative Western blot images above corresponding bars.
Bars represent normalized mean + SEM (ethanol, n=6; sucrose, n=7).
doi:10.1371/journal.pone.0024364.g003
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up-regulates L1 expression, which could compensate for ethanol
inhibition of L1 function. Treatment of cells with NAP, alone or in
combination with ethanol, had no effect on L1 protein expression at
any of the time points in any of the in vitro model systems. Similar
concentrations of NAP induced axon outgrowth in CGNs and blocked
ethanol-induced teratogenesis in mouse embryos [12,46]. Therefore, it
is unlikely that NAP prevents ethanol teratogenesis by regulating the
expression of L1. In addition to blocking ethanol inhibition of L1
adhesion, NAP might prevent ethanol teratogenesis by blocking
ethanol-induced decreases in levels of reduced glutathione and in
GABAAb3 receptor and BDNF gene expression [15,55,56].
Ethanol does not regulate L1 expression in adult
cerebellum
Cerebellar atrophy is a common finding in alcoholics in both
imaging and autopsy studies [57,58]. Because L1 is a neuronal survival
factor, ethanol effects on L1 expression could mediate alcoholic
cerebellar degeneration. Our data demonstrate that one year of binge
drinking to intoxicating blood ethanol concentrations did not alter L1
gene and protein expressionin adultcerebellum. Thesefindingsmakeit
less likely that ethanol causes cerebellar degeneration in part by down-
regulating L1 expression. Further studies with other alcohol exposure
paradigms and in other species would strengthen this conclusion.
Materials and Methods
Materials
Sprague Dawley rats from Charles River Laboratories (Wil-
mington, MA) were used for all cell and tissue culture experiments.
Mothers and pups were allowed to acclimate for at least 24 hr
prior to sacrifice. Male Long Evans rats (average age 7 weeks) were
purchased from Harlan (Indianapolis, IN) and had an average
body weight of 225 g at the start of training in binge-drinking
experiments. Subjects were allowed to acclimate to the new
environment for 5 days prior to any treatment. All animals were
maintained on a light/dark cycle (0600 h to 1800 h) with access to
food and water ad libitum. Animal care procedures were conducted
in accordance with NIH guidelines and the approval of the
Institutional Animal Care and Use Committees at the VA Boston
Healthcare System and Boston University School of Medicine.
Neurobasal medium, Dulbecco’s Modified Eagle Medium
(DMEM), Hank’s Balanced Salt Solution (HBSS), horse serum,
bovine serum, Penicillin-Streptomycin-L-Glutamine (PSG), Peni-
cillin-streptomycin (PS), HEPES buffer, and L-glutamine were
acquired from Gibco (Carlsbad, CA). Glasgow Minimal Essential
Medium (MEM), glucose, sodium bicarbonate, human apo-
transferrin, L-thyroxine, selenium selenate, bovine insulin, bovine
aprotinin, albumin from bovine serum (BSA), poly-L-lysine (pLL),
and anti-GFAP antibody were acquired from Sigma Aldrich (St.
Louis, MO). Hyclone bovine calf serum was obtained from
Thermo Scientific (Waltham, MA), trypsin and DNase were
obtained from Worthington (Lakewood, NJ), and 106HBSS was
obtained from Cellgro (Manassas, VA). Millipore (Billerica, MA)
Millicell cell culture inserts were used in slice culture. Ethanol
(anhydrous, 200-proof) from Sigma Aldrich was used for all
treatments in cell and tissue culture. In the binge drinking
experiments the ethanol solution was diluted from non-denatured
200-proof ethanol obtained from Pharmaco-AAPER, (Brook-
field,CT), and the sucrose solution was made with DominoH sugar.
The NAP peptide (NAPVSIPQ) was synthesized by New England
Peptide (Gardner, MA).
All RNA preparation reagents were obtained from Qiagen
(Valencia, CA), with the exception of ethanol from Sigma Aldrich
and chloroform from Shelton Scientific (Shelton, CT). The RNA
Nano Chip kit was acquired from Agilent (Santa Clara, CA). All
reverse transcriptase PCR and quantitative PCR reagents were
obtained from Promega (Madison, WI), with the exception of
target-specific primers, which were synthesized by Invitrogen
(Carlsbad, CA).
Radio-immunoprecipitation assay (RIPA) buffer, SDS-Tris-
Glycine running buffer, transfer buffer, Tris-buffered saline
(TBS), and Tris-buffered saline with Tween 20 (TBST) were from
Boston BioProducts (Ashland, MA). Bovine serum albumin (BSA)
fraction V was obtained from EMD (Gibbstown, NJ), instant non-
fat dry milk was purchased at a local grocery store, and methanol
was purchased from Sigma Aldrich. Complete Mini EDTA-free
protease inhibitor cocktail was obtained from Roche (Basel,
Switzerland). HALT phosphatase inhibitor, Pierce BCA protein
concentration assay kit, and Pierce ECL Western blotting
substrate were purchased from Thermo Scientific. Mini-PROTE-
AN TGX pre-cast gels (4–15%) and Trans-Blot nitrocellulose
membranes were obtained from BioRad (Hercules, CA), and Re-
blot Plus was acquired from Millipore. L1 goat polyclonal primary
antibody (SC1508) and rabbit polyclonal ß-tubulin antibody
(SC9104) were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA), and all secondary antibodies were acquired from
Jackson ImmunoResearch (West Grove, PA).
Culture of cerebellar slices, CGNs, and astrocytes
All cultured cells and tissues were derived from PD7 rat
cerebella. Pups were sacrificed with CO2, followed by cervical
dislocation and decapitation. Cerebella were removed and
meninges and blood vessels were dissected away in ice-cold
HHGN (HBSS with 2.5 mM HEPES, 35 mM glucose, and 4 mM
sodium bicarbonate).
Cerebellar slices were prepared as previously described [59].
Briefly, cerebella were cut into 350 mm slices using an 800 series
McIlwain Tissue Chopper. Slices were manually separated and
plated on Millicell cell culture inserts. Cultures were maintained in
Glasgow MEM with 25% horse serum, 12.5 mM HEPES, 2.5%
106HBSS, 1% PSG, and 22 mM glucose.
Primary CGN cultures were prepared as previously described
[60]. Briefly, coarsely-chopped cerebella were incubated in 1%
trypsin/0.05% DNase for 16 min and washed with HBSS. Cells
were dissociated in 0.05% DNase solution by mechanical
trituration. CGNs were separated by centrifugation (120 g)
through a cushion of HBSS and Neurobasal medium with 15%
bovine serum. Pelleted CGNs were washed with HBSS, followed
by culture medium. Cells were plated on pLL-coated plates and
maintained in Neurobasal medium supplemented with 1 mg/ml
BSA, 10 mg/ml human apo-transferrin, 4 nM L-thyroxine, 30 nM
selenium selenate, 1 ml/ml bovine aprotinin, 1 mg/ml insulin, and
2 mM L-glutamine.
Primary astrocytes were cultured as described [61], with
modifications. Total cerebellar cells were dissociated as described
for CGN culture. Cells were plated on pLL-coated plates in
DMEM containing 10% Hyclone bovine calf serum and 1% PS.
After approximately 10 days in culture, cells were shaken at
200 rpm for 6 hours to remove microglia and oligodendrocytes.
Adherent astrocytes were maintained for further culture. Astrocyte
purity was assessed using immunocytochemistry for GFAP and
determined to be greater than 98% in representative cultures (data
not shown).
Slices and CGNs were cultured for 24 to 48 hr before
treatment. Astrocytes were maintained in culture for 3 to 8
passages (6–10 weeks) prior to treatment. All cultures were treated
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10
212 M NAP, or both.
Chronic binge-drinking animal model
Self-administration training was conducted in operant chambers
(Med-Associates, St. Albans, VT) equipped with a light, retractable
lever, and retractable double ball bearing sipper to prevent
leakage. All subjects were initially trained by drinking 10% sucrose
for several days and then randomly divided into ethanol (n=6)
and sucrose (n=7) groups using a modification of the sucrose
fading procedure [62,63]. Training was started on a continuous
reinforcement schedule with a fixed ratio (FR1-FR4) that
transitioned to a response requirement (RR4 to RR20). Subjects
had access to the sipper tube daily for 20 minutes, 5 days per week
and attained an average ethanol daily intake of 1.1560.003 g/kg.
Two weeks prior to the end of the experiment, blood samples were
collected from snipped tails following a 20-minute drinking session.
Blood ethanol concentrations were determined using an Analox
GM7 Analyzer (Analox Instruments, Lunenburg, MA). After one
year of drinking and two hours after the last drink, animals were
sacrificed, and the cerebella were removed for mRNA and
Western blot analysis.
RNA isolation and cDNA synthesis
Total RNA was prepared using RNeasy Lipid Tissue Mini-kit,
following the manufacturer’s protocol. Briefly, Qiazol buffer was
added to all samples. Afterwards, slices were disrupted by manual
grinding and cell culture samples were lysed and suspended by
scraping. All samples were sonicated for 1 min on ice to achieve
complete homogenization. RNA was purified using spin columns.
For chronic binge drinking animals, a portion of each cerebellum
was preserved in RNAlater before processing for RNA prepara-
tion. RNA yield and quality were measured with an RNA Nano
Chip kit using an Agilent Bioanalyzer 2100.
Total RNA samples were reverse-transcribed using GoScript
Reverse Transcription System, following the manufacturer’s proto-
col. Reactions were performed with 0.5 mg total RNA, 0.5 mg
random hexamers, 3.75 mM MgCl2, 0.5 mM PCR nucleotides,
20 URNasin,and1 mLGo Sc r i p tR Te n z y m ei n2 0mL total volume.
RNA and random hexamers were combined and incubated at 70uC
for 5 min before combination with other components. Reactions
were incubated at 25uC for 5 min to allow primer annealing,
followed by 42uC for 1 hr for extension. The RT enzyme was
inactivated by incubation at 70uC for 15 min. ‘‘No RT’’ reactions
were performed for each sample by omitting the RT enzyme.
Quantitative real-time PCR
Primer pairs to amplify L1, 18S, and cyclophilin A (CypA) were
used directly or with modifications from previously published
sequences (Table 2) [64–66]. The sequences were analyzed using
Primer-BLAST (NCBI) to assess amplicon specificity, size, and
location. To confirm primer specificity, melting curves were
performed and showed a single peak for each reaction, indicating a
single amplicon and no primer dimerization. Additionally, gel
electrophoresis confirmed amplicon size.
GoTaq Master Mix kits were used to amplify target genes for
quantitative real time PCR (qPCR). This chemistry utilizes a
SYBR-Green dye analog to bind double-stranded DNA. Reac-
tions were performed in triplicate and each contained 16GoTaq
master mix (12.5 mL), 16 carboxy-X-rhodamine dye (0.25 mL),
100 nM forward and reverse primers, and 10 ng cDNA in 25 mL
total volume. Amplification and data collection were performed in
an ABI 7900 Signal Detector using a 96-well format. Cycling
consisted of an initial denaturation step (95uC for 2 min), followed
by 40 cycles at 95uC for 15 sec and 60uC for 1 min.
Standard curves were constructed by serially diluting purified PCR
products for each gene target. Curves contained six template
concentrations spanning 1 fg to 100 pg and the plots of log-
transformed template concentrations against quantification cycle (Cq)
values showed linear relationships with R
2 values greater than 0.99
for each target. When calculated from these curves, the efficiencies of
L1 and 18S amplification were 85% and 89%, respectively. All
experimental Cq values fell within the range of the standard curves,
insuring that they were above the limit of detection and within the
linear dynamic range. A similar dilution series was prepared with
pooled slice, CGN, and astrocyte cDNA to test for PCR inhibitors. A
linear relationship was seen between log-transformed template
concentrationand Cq value, indicating no significant PCR inhibition.
Additionally, ‘‘no RT’’ reactions were performed for each
sample. cDNA samples were considered free from genomic DNA
contamination if Cq values of ‘‘no RT’’ samples were at least 10
cycles higher than matched sample, or no amplification was seen
within 40 cycles. All samples met this criterion. No-template
control reactions were run on each plate to confirm that no
exogenous DNA contamination was present. A pooled sample in
which all targets were detectable at known levels was run on each
plate as a positive control and to monitor inter-assay variation.
Cell lysate preparation
For total protein preparations, cells and slices were washed once
in ice-cold PBS and lysates were prepared in RIPA buffer with
protease and phosphatase inhibitors. For chronic binge-drinking
animals, cerebellar lysate was prepared in RIPA buffer with
protease and phosphatase inhibitors from fresh tissue. All samples
were sonicated for 1 min on ice and centrifuged at 14,000 rpm for
20 min. The protein concentration in the supernatant was
measured using a BCA Protein Assay Kit.
Western blotting
Cell and tissue lysates (20–50 mg total protein) were separated
by SDS-PAGE electrophoresis, and protein was transferred to
nitrocellulose membranes for 1.5 hours in transfer buffer with
15% methanol. Membranes were blocked for 1 hr in TBST with
2% BSA and 3% milk, then incubated with L1 antibody (1:1000)
in blocking solution for 16–18 hrs at 4uC. Blots were then
incubated with HRP-conjugated anti-goat secondary antibody
(1:4000) in blocking buffer for 1 hr at room temperature. For
detection of b-tubulin, anti-b-tubulin antibody (1:000) and HRP-
conjugated anti-rabbit secondary antibody (1:4000) were used
following the same protocol. Blots were either cut at 75 kD so that
L1 and b-tubulin could be processed simultaneously, or mem-
branes were stripped with Re-Blot Plus following L1 blotting and
Table 2. Primers used for PCR amplification of target genes.
Target (RefSeq) Primer sequence Location
L1 (NM_017345) F-GCCTGACACCAAATATGAGATCCACC 3346
R-CTGACAAAGGCGATGAACCA 3489
18S (M11188.1) F-GGACACGACAGGATTGACA 1278
R-ACCCACGGATCGAGAAAGA 1327
CypA (NM_017101.1) F-TGTGCCAGGGTGGTGACTT 224
R-TCAAATTTCTCTCCGTAGATGGACTT 293
doi:10.1371/journal.pone.0024364.t002
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with ECL Western blot substrate, and blots were then exposed to
x-ray film and developed.
Data analysis
All real time PCR data were managed and analyzed using the
web-base JAVA application QPCR [67] (http://esus.genome.
tugraz.at/rtpcr). The AnalyzerMiner algorithm was used to
generate efficiency and Cq values for each reaction and to
perform endogenous control normalization and efficiency correc-
tions [68]. Permutation mean tests (performed in the QPCR
application) were used to generate relative expression values and
corresponding standard error values for each statistical class and to
determine statistical significance.
For Western blotting, films were scanned and densitometry was
performed using TINA 2.0 software. For each sample, L1 OD-
background values were normalized to corresponding b-tubulin
values and then, within each experiment, the control sample was
set to 100% and all treatments were scaled accordingly. GraphPad
Prism v4.0 was used to perform the one-sample t-test comparing
the normalized means of treatment groups to 100%, the relative
value assigned to control.
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